Marinova achieves EU organic certification for fucoidan extracts
Australian biotechnology company Marinova has secured EU organic certification for its Maritech® organic fucoidans portfolio, adding to its existing regulatory credentials including EU Novel Foods authorisation and FDA-notified GRAS status.
The certification represents the latest accreditation for Marinova’s seaweed-derived bioactive compounds, which are incorporated into dietary supplements, medical devices, and skincare formulations. The high purity extracts are sustainably sourced and clinically validated, positioning them as premium ingredients for healthcare applications.
Sustainability recognition drives market positioning
Marinova’s environmental stewardship has garnered significant industry recognition, with the company recently securing the 2025 national winner title in the Healthy Planet, Healthy People category at Australia’s Banksia National Sustainability Awards. The company also received awards from the Telstra Best of Business Awards and The Australian Export Awards for sustainability initiatives.
Regulatory compliance strengthens market access
The Maritech organic fucoidan range maintains compliance across multiple international standards, including USDA National Organic Program certification alongside the newly achieved EU organic status. According to Marinova’s Quality Manager Dr Michelle Mendoza: “Attaining EU organic certification provides additional confidence for formulators and consumers alike. Maritech organic fucoidans tick all the boxes. They are natural, efficacious and supported by a sustainable and transparent supply chain that is regularly and independently audited.”
The company positions its fucoidan extracts as the world’s only high purity, certified organic fucoidan with global regulatory acceptance, supported by extensive scientific documentation.
For more information, visit: https://maritechfucoidan.com.au
Digital issue: Please click here for more information
